Surrozen, Inc.

171 Oyster Point Boulevard
Suite 400
South San Francisco
United States

Show jobs for this employer

About Surrozen, Inc.

Surrozen is discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway.

The Wnt pathway plays a critical role in stem cell maintenance, tissue regeneration and other important developmental processes. Abnormalities in the Wnt pathway have been linked to many human diseases, revealing a powerful underlying biology with relevance to a broad spectrum of organs and tissues. Surrozen is implementing a platform of “surrogate” Wnt molecules to selectively activate the Wnt pathway for the treatment of injury and disease—overcoming key hurdles that have held back industry-wide drug development efforts in this promising area of biology.


February 2017


Founders: K. Christopher Garcia, Ph.D., Roeland Nusse, Ph.D., Calvin Kuo, M.D., Ph.D. and Claudia Janda, Ph.D.

CEO: Tim Kutzkey, Ph.D.

CSO: Wen-Chen Yeh, M.D., Ph.D.

Senior Director and Head of Discovery Biology: Yang Li, Ph.D.

3 articles with Surrozen, Inc.